US Patent 9045551 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof
Patent 9045551 was granted and assigned to AbbVie Inc. on June, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 28 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+340 characters)
Article
Patent abstract
Disclosed herein are multivalent and multispecific binding proteins, methods of making the binding proteins, and their uses in the diagnosis, monitoring, inhibition, prevention and/or treatment of cancers, tumors, and/or other angiogenesis-dependent diseases characterized by aberrant DLL4 and/or VEGF expression or activity.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09045551 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof US Patent 9045551 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof
Infobox
Patent Number
0904555100
Patent Number
904555100
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
090455510
Date of Patent
June 2, 2015
0Patent Application Number
143015460
Date Filed
June 11, 2014
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
090455510
Date of Patent
June 2, 2015
0Patent Application Number
143015460
Date Filed
June 11, 2014
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09045551 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09045551
Date of patent
June 2, 2015
Patent application number
14301546
Date Filed
June 11, 2014
Patent primary examiner
Find more entities like US Patent 9045551 Anti-DLL4/VEGF dual variable domain immunoglobulin and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
